In an article published very recently in Pediatric Blood and Cancer by the COG entitled : A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic ewing sarcoma family of tumors: A Children’s Oncology Group (COG) phase II study (NCT00061893) that aimed at determining the feasibility of the combination of metronomic chemotherapy with celecoxib and vinblastine together with standard therapy for (…)